Category: Jurisdictions
-
Comcast must pay WhereverTV $213 million for infringing X1 program guide patent, Florida jury finds
A Tampa jury found Comcast’s Xfinity X1 guide infringes WhereverTV’s patent, in a case the Federal Circuit revived last year. Post-trial motions come next, Comcast has signaled an appeal.
-
BREAKING: Ericsson sues Disney in Brazil over multimedia patents
Ericsson has filed a patent infringement dispute against Disney in the Rio de Janeiro court over several multimedia patents.
-
Apple asks court to wipe out Taction’s $5.7B verdict, files JMOL motion three days ahead of deadline
Filed three days ahead of the deadline, Apple’s renewed JMOL motion claims the jury had no evidence for $5.7B and that Taction’s infringement test was rigged. Taction’s response is now due November 3.
-
Longhorn IP entity files German complaint against farm equipment maker AGCO
The Dusseldorf suit adds to the SEP complaint AGCO is already facing across the country in Munich.
-
Samsung and Pictiva settle OLED patent dispute that saw $191M Texas jury verdict followed by PTAB invalidation
The two parties have jointly moved to dismiss litigation in the Eastern District of Texas.
-
Qualcomm, Arm each claim victory in architecture licensing standoff; jury awards $2 damages
The two chipmakers have been engaged in a long-running contractual dispute over use of Arm’s processor architecture IP.
-
UK government rejects new FRAND rate-setting track in SEP policy response
The UK government has rejected a dedicated FRAND rate-setting track in favor of exploring early judicial evaluation and non-binding IPO opinions, while leaving the existing injunction framework unchanged.
-
MIT enforces cloud and IoT chip security patents against Amazon Web Services, Microsoft in U.S.
The asserted quasi-SEPs relate to physical unclonable function (PUF) technology, which has important applications in authentication and cryptography.
-
EPO Board of Appeal revokes Novo Nordisk’s cardiovascular semaglutide patent; generics could enter EU as early as 2031
The Board found the claims lacked priority, so a clinical study publication destroyed novelty, leaving Ozempic and Wegovy potentially vulnerable to competition earlier than expected.
-
SK hynix sues Longhorn IP again, alleging repeated patent demands through affiliates
SK hynix has taken Longhorn IP back to court, challenging infringement allegations over eight former TSMC patents and accusing the licensing company of using a new affiliate to pursue additional licensing demands despite earlier agreements.